Journal of Antimicrobial Chemotherapy · 1987 · 30 citations · 0 references
PharmacyInfectious DiseasesPharmacologyAntimicrobial PharmacologyAntimicrobial PharmacotherapyInfectious Disease PharmacotherapyAntimicrobial DosingPharmacokinetics Of AntimicrobialsPulmonary PharmacokineticsVeterinary Antimicrobial TherapyAntibiotic Dosing RegimensDaily DosingPharmacokinetics Of Veterinary AntimicrobialsRespiratory Bacterial Infections TreatmentRespiratory Tract Infection TreatmentSurvival RatesTherapeutic Efficacy Assessment
The efficacy of different dosing schedules of tobramycin for treating a murine Klebsiella bronchopneumonia was compared. Therapeutic efficacy depended upon dosing intervals. In mice treated for four days with a daily dose of 48 mg/kg, dosing intervals of 4 and 8 h allowed cure of 10/10 animals, whereas dosing intervals of 12 and 24 h yielded survival rates of only 6/10 (P less than 0.05) and 2/10 (P less than 0.01) respectively. Although observed in vitro, a post-antibiotic effect of tobramycin against K. pneumoniae was unlikely in vivo since residual concentrations of tobramycin were found in the lung tissue 12 h after dosing, when efficacy starts to decrease. Efficacy also depended to some extent upon the duration of therapy.